These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112 [TBL] [Abstract][Full Text] [Related]
24. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
25. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA. Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296 [TBL] [Abstract][Full Text] [Related]
26. Rate constant of gadolinium (Gd)-DTPA transfer into chronic subdural hematomas. Mori K; Mitsuoka H; Cho K; Tajima A; Maeda M Neurol Res; 1996 Apr; 18(2):126-34. PubMed ID: 9162866 [TBL] [Abstract][Full Text] [Related]
27. Gd-DOTA: characterization of a new paramagnetic complex. Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763 [TBL] [Abstract][Full Text] [Related]
28. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings. Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741 [TBL] [Abstract][Full Text] [Related]
29. Biodistribution and magnetic resonance imaging of cross-linked DTPA polysaccharides. Gibby WA; Billings J; Hall J; Ovitt TW Invest Radiol; 1990 Feb; 25(2):164-72. PubMed ID: 1690184 [TBL] [Abstract][Full Text] [Related]
30. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Press WR; Weinmann HJ Invest Radiol; 1991 Nov; 26(11):969-74. PubMed ID: 1743920 [TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging increases the blood-brain barrier permeability to 153-gadolinium diethylenetriaminepentaacetic acid in rats. Prato FS; Frappier JR; Shivers RR; Kavaliers M; Zabel P; Drost D; Lee TY Brain Res; 1990 Jul; 523(2):301-4. PubMed ID: 2400915 [TBL] [Abstract][Full Text] [Related]
32. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings. Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related]
34. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. Schmiedl U; Brasch RC; Ogan MD; Moseley ME Acta Radiol Suppl; 1990; 374():99-102. PubMed ID: 1966977 [TBL] [Abstract][Full Text] [Related]
35. Dyke Award. Europium-DTPA: a gadolinium analogue traceable by fluorescence microscopy. Elster AD; Jackels SC; Allen NS; Marrache RC AJNR Am J Neuroradiol; 1989; 10(6):1137-44. PubMed ID: 2512774 [TBL] [Abstract][Full Text] [Related]
36. MRI of the TMJ disc with intravenous administration of gadopentetate dimeglumine. Takebayashi S; Takama T; Okada S; Masuda G; Matsubara S J Comput Assist Tomogr; 1997; 21(2):209-15. PubMed ID: 9071286 [TBL] [Abstract][Full Text] [Related]
37. Gd-DTPA enhancement of CSF in meningeal carcinomatosis. Pui MH; Langston JW; Arai Y J Comput Assist Tomogr; 1993; 17(6):940-4. PubMed ID: 8227581 [TBL] [Abstract][Full Text] [Related]
38. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types]. Yoshida K; Furuse M; Kaneoke Y; Sasou K; Motegi Y No To Shinkei; 1988 Jun; 40(6):531-7. PubMed ID: 3224029 [TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Kermode AG; Tofts PS; Thompson AJ; MacManus DG; Rudge P; Kendall BE; Kingsley DP; Moseley IF; du Boulay EP; McDonald WI Neurology; 1990 Feb; 40(2):229-35. PubMed ID: 2300240 [TBL] [Abstract][Full Text] [Related]
40. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats. Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]